Plozasiran is an apoC-III-directed small interfering ribonucleic acid designed to reduce levels of hepatic and serum apoC-III ...

According to the US Department of Health and Human Services, research plans to investigate all the possible causes of autism are in the works.

Osvyrti is suppled as a 60mg/mL single-dose prefilled syringe for SC administration and Jubereq is supplied as 120mg/1.7mL single-dose vial for SC administration.

Increased rate of major bleeding and lower mortality rates observed, resulting in greater net clinical benefit.

Overall survival data showed a 50% reduction in the risk of death with the regimen compared with surgery alone.

Tonmya now available for fibromyalgia; safety warnings for DMD treatment; mitapivat shows mixed results in sickle cell disease trial; Redemplo approved for familial chylomicronemia syndrome; Hyrnuo ...

The prevalence of childhood hypertension nearly doubled between 2000 and 2020, from 3.40 to 6.53% in boys and from 3.02 to 5.82% in girls. HealthDay News — The prevalence of childhood hypertension is ...

Proportion of physicians with MHSU care stable prepandemic, then increased, with larger increases seen during first two years of pandemic.

Darzalex Faspro ® is a subcutaneous formulation that combines daratumumab, a CD38-directed cytolytic antibody, and hyaluronidase, an endoglycosidase that increases permeability of the subcutaneous ...

The FDA also approved an every 4 week dosing regimen across all approved indications for patients who may not maintain a response on extended dosing intervals following successful initial treatment.

The Food and Drug Administration (FDA) has approved Koselugo ® (selumetinib) for adults with neurofibromatosis type 1 (NF1) who have symptomatic, inoperable plexiform neurofibromas (PN). Previously, ...